NCT02867397View on ClinicalTrials.gov

Study of Teysuno (S-1) Combined With Epirubicin and Oxaliplatin in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Patients With Advanced or Metastatic Solid Tumors
Interventions
DRUG

Teysuno (S1) in combination with epirubicin and oxaliplatin

Sponsors
All Listed Sponsors
lead

Disphar International B.V.

INDUSTRY